ENGLEWOOD, CO / ACCESSWIRE / August 24, 2020 / Lightwave Logic, Inc. (OTCQB:LWLG), a technology platform company leveraging its proprietary electro-optic polymers to transmit data at higher speeds with less power, today announced that management will present at the LD 500 virtual investor conference, hosted by LD Micro and taking place virtually September 1 – 4, 2020.

Jim Marcelli, President of Lightwave Logic, is scheduled to host a virtual presentation during the conference as follows and will participate in one-on-one meetings throughout the day.

LD 500 Virtual Investor Conference
Date: Wednesday, September 2, 2020
Time: 12:40 p.m. Eastern time (9:40 a.m. Pacific time) – Track 2
Webcast: https://www.webcaster4.com/Webcast/Page/2019/36176

A live audio webcast and archive of the conference presentation will be available using the webcast link above. For more information on the LD 500 virtual investor conference or to schedule a one-on-one, please contact your LD Micro representative.

About Lightwave Logic, Inc.
Lightwave Logic, Inc. (OTCQB:LWLG) is developing a platform leveraging its proprietary engineered electro-optic (EO) polymers to transmit data at higher speeds with less power. The Company's high-activity and high-stability organic polymers allow Lightwave Logic to create next-generation photonic EO devices, which convert data from electrical signals into optical signals, for applications in data communications and telecommunications markets. For more information, please visit the Company's website at lightwavelogic.com.

Safe Harbor Statement
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, lack of available funding; general economic and business conditions; competition from third parties; intellectual property rights of third parties; regulatory constraints; changes in technology and methods of marketing; delays in completing various engineering and manufacturing programs; changes in customer order patterns; changes in product mix; success in technological advances and delivering technological innovations; shortages in components; production delays due to performance quality issues with outsourced components; those events and factors described by us in Item 1.A "Risk Factors" in our most recent Form 10-K and Form 10-Q; other risks to which our Company is subject; other factors beyond the Company's control.

Investor Relations Contact:
Greg Falesnik or Luke Zimmerman
MZ Group – MZ North America
949-385-6449
LWLG@mzgroup.us
www.mzgroup.us

SOURCE: Lightwave Logic, Inc.

ReleaseID: 602484

CARLSBAD and NOVATO, CA / ACCESSWIRE / August 24, 2020 / Patriot Scientific Corporation (the "Company" or "Patriot") (OTC PINK:PTSC) and Mosaic ImmunoEngineering Inc., ("Mosaic") announced today that they have entered into a definitive agreement under which a wholly-owned subsidiary of Patriot will merge with Mosaic through the issuance of convertible preferred stock. The merged company will focus on advancing its immunotherapy pipeline of products including intra-tumoral immunotherapy of cancer and its modular vaccine platform.

"Patriot was able to create substantial shareholder value for many years through licensing of our broad microprocessor intellectual property patents. However, we recently began to evaluate new opportunities to create stockholder value with the expiration of our patents and unsuccessful court appeals. As part of this process, we evaluated a number of opportunities and we believe that the technology platform at Mosaic has the opportunity to create tremendous shareholder value." said Carlton Johnson, interim president and interim chief financial officer of Patriot. "Mosaic has a broad technology platform with potential in cancer and infectious diseases. We believe this union represents a great opportunity for the stockholders of both companies."

As part of the merger, Mr. Johnson will remain onboard in his executive duties through August 28th to ensure a smooth management transition.

"We appreciate the thorough approach that the board of directors at Patriot took in considering strategic alternatives and we feel that this union has the potential to create significant value for stockholders of both companies moving forward." stated Steven King, president and CEO of Mosaic. "Our technology platforms have broad potential to treat and prevent diseases that span oncology and infectious diseases. The underlying research supporting our product pipeline and technology platforms has been extensive over the past 10 years with funding of over $20 million. We look forward to providing more details regarding our development plans in these areas over the coming weeks."

About the Transaction

The merger is structured as a stock-for-stock transaction whereby all of Mosaic's outstanding shares of Class A and Class B common stock will be exchanged for Patriot's Series A and Series B Preferred Stock. A subsidiary of Patriot will buy from the stockholders of Mosaic 630,000 shares of its Class A common stock and 70,000 shares of its Class B common stock, representing 100% of the issued and outstanding common stock of Mosaic, in exchange for 630,000 shares of the Patriot's Series A Convertible Preferred Stock ("Series Preferred") and 70,000 shares of Patriot's Series B Convertible Preferred Stock ("Series B preferred), respectively. Each share of the Series A Preferred; shall (a) convert into 5,097.053 shares of common stock of the Parent, (b) possess full voting rights, on an as-converted basis, as the common stock of the Parent, and (c) have no dividend rate. Each share of the Series B Preferred; shall (a) convert into 5,734.185 shares of common stock of the Parent, (b) possess full voting rights, on an as-converted basis, as the common stock of the Parent, (c) have no dividend rate, and (d) shall possess certain anti-dilution protections as defined in the Series B Certificate of Designations. On a fully diluted, as converted basis, it is anticipated that Patriot's equityholders immediately prior to the merger will own 10% of the combined company and Mosaic's equityholders immediately prior to the merger will own 90% of the combined company.

Law Office of Otto E. Sorensen is serving as legal counsel to Patriot and Duane Morris LLP is serving as legal counsel to Mosaic IE.

No Offer or Solicitation

This communication will not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor will there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities in connection with the proposed merger shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

A more complete description of the terms of and conditions of the transaction can be found in Patriots' Form 8-K to be filed with the SEC on August 25, 2020, and in the Stock Purchase Agreement, which will be filed as an exhibit to that Form 8-K.

About Patriot Scientific Corporation

Patriot Scientific Corporation is publicly traded company with a long history focused on licensing its patented microprocessor technologies through broad and open licensing and by litigating against those who may have infringed on its patents. The company has licensed its technology to over 100 companies through its joint-venture Phoenix Digital Solutions. On November 4, 2019, the Supreme Court of the United States denied its application to review a lower court's decision that was adverse to its patented microprocessor technologies and its patents were no longer enforceable, and therefore, company had begun planning for its future by exploring alternatives and a new line of business.

About Mosaic ImmunoEngineering Inc.

Mosaic ImmunoEngineering Inc. is a private biotechnology company focused on bridging immunology and engineering to develop novel immunotherapies to treat and prevent cancer and infectious diseases. Mosaic is developing virus-like nanoparticle-based ("VLP") technologies for the treatment and prevention of cancer and infectious diseases in humans and for veterinary use. The technology has broad potential for the treatment of many different types of cancer and the lead product candidates supported by numerous publications and grant funding. In addition, the technology also has direct application as part of a vaccine platform which has already generated promising data in both cancer and infectious diseases, including COVID-19 through research that is being funded by the National Science Foundation. For additional information about Mosaic, please visit MosaicIE.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and other Federal securities laws. For example, we are using forward-looking statements when we discuss Patriot's future operations and its ability to successfully initiate and complete clinical trials and achieve regulatory milestones and related timing; the nature, strategy and focus of Patriot's business; and the development and commercial potential and potential benefits of any of Patriot's product candidates. Patriot may not actually achieve the plans, carry out the intentions or meet the expectations or projections disclosed in the forward-looking statements and you should not place undue reliance on these forward-looking statements. Because such statements deal with future events and are based on Patriot's current expectations, they are subject to various risks and uncertainties and actual results, performance or achievements of Patriot that could differ materially from those described in or implied by the statements in this press release, including: the uncertainties associated with advancing Mosaic's multiple products into clinical trials, the clinical development and regulatory approval of Mosaic's product candidates, including potential delays in the commencement, enrollment and completion of clinical trials; the potential that earlier preclinical studies of Mosaic's product candidates may not be predictive of future results; risks related to business interruptions, including the outbreak of COVID-19 coronavirus, which could seriously harm Patriot's financial condition and increase its costs and expenses; and the requirement for additional capital to continue to advance these product candidates, which may not be available on favorable terms or at all. The foregoing review of important factors that could cause actual events to differ from expectations should not be construed as exhaustive and should be read in conjunction with statements that are included herein and elsewhere, including the those risks discussed in Patriot's filings with the Securities and Exchange Commission. Except as otherwise required by law, Patriot disclaims any intention or obligation to update or revise any forward-looking statements, which speak only as of the date hereof, whether, as a result of new information, future events or circumstances or otherwise.

CONTACT:

Steven King, President and CEO
Mosaic ImmunoEngineering Inc.
info@mosaicie.com

SOURCE: Patriot Scientific Corporation

ReleaseID: 602904

QUEBEC, QC / ACCESSWIRE / August 24, 2020 / SOCIÉTÉ D'EXPLORATION MINIÈRE VIOR INC. (TSXV:VIO)(FRANKFURT:VL51) – wishes to announce the acquisition of a 100%-interest in 50 additional claims adjacent to the Skyfall project, in the eastern part of the Urban-Barry gold belt, located approximately 150 kilometers east of Lebel-sur-Quevillon and 75 kilometers to the south of Chapais, Quebec. These new claims are in addition to the 215 existing, bringing Vior's total claims package to 265 claims. The Skyfall project now encompasses an area of 149.3 square kilometers, making it one of the largest land positions held by a company in the Urban-Barry volcanic belt.

The Skyfall project is located in an under-explored area of ​​the Urban-Barry volcanic belt, approximately 40 kilometers east of Osisko Mining's Windfall, and Bonterra Resources' Barry and Gladiator gold deposits (see figure, reference to Mineral Resources is taken from Osisko Mining and Bonterra Resources websites). The project is covered by sequences of volcanic rocks crosscut by series of faults oriented sub-parallel to the stratigraphy or trending north-northeast in which gold mineralization is often associated in the area.

Due to its limited land access until a few years ago, very little exploration work has been done on Skyfall. The project shows a geological environment similar to that of the central part of the Urban-Barry belt in which we find many gold deposits and showings (please note however that the mineralization hosted on adjacent and/or nearby properties is not necessarily indicative of mineralization hosted on the Company's property).

Vior has acquired a 100% interest in 50 new claims. A cash payment and the issuance of shares has been made to one of two sellers for 35 claims, while a cash payment was made to the other seller for 12 claims. The remaining 3 claims were acquired by map designation. A 2% net smelter return ("NSR") has been granted to the two sellers, of which 1% may be repurchased from one of the sellers. The acquisition of 35 of the claims will be subject to TSX-V approval.

A comprehensive exploration program will begin on Skyfall in late August, 2020. This will include a first phase of systematic till sampling, as well as geological field prospecting, including rock sampling. A second phase of work is also scheduled for Fall 2020 on the new gold targets generated.

Qualified Person

The technical content disclosed in this press release was reviewed and approved by Mr. Marc L'Heureux, P.Geo., who is the Company's Qualified Person as per NI 43-101.

About Vior

Vior is a junior mining exploration company based in Quebec whose corporate strategy is to generate, explore, and develop high quality projects in proven and favourable mining jurisdictions in North America. Through the years, Vior's management and technical team have demonstrated their ability to discover several gold deposits and many high-quality mineral prospects.

For further information, please contact:

Mark Fedosiewich
President and CEO
Tel.: 613-898-5052
mfedosiewich@vior.ca

Marc L'Heureux
Vice-president, Exploration
Tel.: 450-646-1790
mlheureux@vior.ca

Website: www.vior.ca
SEDAR: Société d'exploration minière Vior inc.

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the Policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the Policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Société d'exploration minière Vior inc.

ReleaseID: 602938

Company leveraging its carbon processing capacity to bolster efficiencies and further lower its cost structure

Perry County Resources restructured to be one of the lowest cost and most innovative PCI (pulverized coal injection) and stoker operations in the United States

FISHERS, IN / ACCESSWIRE / August 24, 2020 / American Resources Corporation (NASDAQ:AREC) ("American Resources" or the "Company"), a supplier of raw materials to the rapidly growing global infrastructure marketplace, announced today that it has entered into a carbon processing, transloading agreement with a third-party operator. Under the agreement, American Resources will provide, among other things, carbon processing, storage and rail and/or truck loading services at its Davidson Branch Preparation Plant located at the Company's Perry County Resources complex in Hazard, Kentucky. The agreement commences immediately under an initial trial period and will then carry a one-year term should the trial be favorable for both parties. The agreement will have the option to renew on an annual basis.

"We are constantly evaluating opportunities to secure strong, joint venture partnerships to reinforce our growth and at the same time enhance our efficiencies and profitability", stated Mark Jensen, Chairman and CEO of American Resources Corporation. "Having the ability to leverage our large infrastructure base to process third-party carbon further demonstrates our ability to maximize the value of our assets and allows us to increase our efficiencies to further reduce our operating costs at the Perry County complex, thereby reducing the overall processing cost for all carbon processed at the facility. We are very proud of the work we have done at Perry County to position it as the most innovative and lowest cost PCI, stoker and specialty carbon facilities in the United States."

Consistent with American Resources' philosophy of focusing on raw materials that go into infrastructure and specialty products, the carbon being processed under this agreement is considered one of the most specialized grades of carbon known as Blue Gem. This specific type of carbon is used in a variety of industrial and technology applications that utilize silicon and ferrous metal alloys. Under the agreement, American Resources will have the ability to purchase certain carbon qualities and products from the third party for its own orders of high-quality metallurgical carbon.

The Davidson Branch Preparation Plant has a total capacity to process 1,300 tons of carbon per hour, equipped with multiple stoker circuits to process a variety of finished products. This American Resources complex was chosen due to its highly specialized facilities and its ability to process carbon to variety of specific specifications for its customers.

About American Resources Corporation

American Resources Corporation is a supplier of high-quality raw materials to the rapidly growing global infrastructure market. The Company is focused on the extraction and processing of metallurgical carbon, an essential ingredient used in steelmaking. American Resources has a growing portfolio of operations located in the Central Appalachian basin of eastern Kentucky and southern West Virginia where premium quality metallurgical carbon deposits are concentrated.

American Resources has established a nimble, low-cost business model centered on growth, which provides a significant opportunity to scale its portfolio of assets to meet the growing global infrastructure market while also continuing to acquire operations and significantly reduce their legacy industry risks. Its streamlined and efficient operations are able to maximize margins while reducing costs. For more information visit americanresourcescorp.com or connect with the Company on Facebook, Twitter, and LinkedIn.

Special Note Regarding Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks, uncertainties, and other important factors that could cause the Company's actual results, performance, or achievements or industry results to differ materially from any future results, performance, or achievements expressed or implied by these forward-looking statements. These statements are subject to a number of risks and uncertainties, many of which are beyond American Resources Corporation's control. The words "believes", "may", "will", "should", "would", "could", "continue", "seeks", "anticipates", "plans", "expects", "intends", "estimates", or similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. Any forward-looking statements included in this press release are made only as of the date of this release. The Company does not undertake any obligation to update or supplement any forward-looking statements to reflect subsequent events or circumstances. The Company cannot assure you that the projected results or events will be achieved.

PR Contact:

Precision Public Relations
Matt Sheldon
917-280-7329
matt@precisionpr.co

Investor Contact:

JTC Team, LLC
Jenene Thomas
833-475-8247
AREC@jtcir.com

Company Contact:

Mark LaVerghetta
317-855-9926 ext. 0
Vice President of Corporate Finance and Communications
investor@americanresourcescorp.com

SOURCE: American Resources Corporation

ReleaseID: 602931

Celebrating the Start of Construction for its

Commercial Lithium-Ion Battery Recycling Pilot Plant

INCLINE VILLAGE, NV / ACCESSWIRE / August 24, 2020 / American Battery Metals Corporation (OTCQB:ABML) (the "Company"), an American-owned lithium-ion battery recycling technology and advanced extraction company with extensive mineral resources in Nevada, is pleased to announce the scheduling of its ground breaking ceremony for its commercial lithium-ion battery recycling pilot plant for Thursday, August 27. The ceremony celebrating the start of construction will begin at 2pm at 354 Winston Lane in Fernley, Nevada.

GROUNDBREAKING CEREMONY
Thursday, August 27 at 2pm
354 Winston Lane, Fernley, Nevada

Doug Cole, Chief Executive Officer of American Battery Metals Corporation, commented, "This event has been a long time coming as our team has put a lot of hard work to get to this point. We are extremely excited for this ground breaking and the work ahead of us to get the plant operational. We will be joined by local government officials who have really supported our efforts and champion our vision for lithium-ion battery recycling and clean sustainable energy. If you would like to join us at the ground breaking, please contact Katie Baker, our Corporate Communications leader, at 925-330-4450."

American Battery Metals Corporation

American Battery Metals Corporation (www.batterymetals.com) (OTCQB:ABML) is an American-owned lithium-ion battery recycling technology and advanced extraction company with extensive mineral resources in Nevada. The company is focused on its lithium-ion battery recycling and resource production projects in Nevada, with the goal of becoming a substantial domestic supplier of battery metals to the rapidly growing electric vehicle and battery storage markets.

For more information, please visit:www.batterymetals.com

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, including those with respect to the expected project economics for Western Nevada Basin (Railroad Valley), including estimates of life of mine, average production, cash costs, AISC, initial CAPEX, sustaining CAPEX, pre-tax IRR, pre-tax NPV, net cash flows and recovery rates, the impact of self-mining versus contract mining, the timing to obtain necessary permits, the submission of the project for final investment approval and the timing of initial gold production after investment approval and full financing, metallurgy and processing expectations, the mineral resource estimate, expectations regarding the ability to expand the mineral resource through future drilling, ongoing work to be conducted at the Western Nevada Basin (Railroad Valley), and the potential results of such efforts, the potential commissioning of a Pre-Feasibility study and the effects on timing of the project, are "forward-looking statements." Although the Company's management believes that such forward-looking statements are reasonable, it cannot guarantee that such expectations are, or will be, correct. These forward-looking statements involve a number of risks and uncertainties, which could cause the Company's future results to differ materially from those anticipated. Potential risks and uncertainties include, among others, interpretations or reinterpretations of geologic information, unfavorable exploration results, inability to obtain permits required for future exploration, development or production, general economic conditions and conditions affecting the industries in which the Company operates; the uncertainty of regulatory requirements and approvals; fluctuating mineral and commodity prices, final investment approval and the ability to obtain necessary financing on acceptable terms or at all. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company's filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K for the year ended September 30, 2019. The Company assumes no obligation to update any of the information contained or referenced in this press release.

Contact Information
p775-473-4744
info@batterymetals.com

SOURCE: American Battery Metals Corporation

ReleaseID: 602956

Viflip is the innovative real estate company that has just arrived in the United States and proposes a unique method to help the owner make more money by selling their property with zero risk.

MADRID, SPAIN / ACCESSWIRE / August 24, 2020 / Viflip, a real estate company owned by Spaniards César Rivero , José Llanos and Gennaro Auletta, has just landed in the United States with a unique proposal: to help owners sell their property… for more money than they have in mind and without risking their own.

To do so, they propose an evolution of the traditional Flipping House based on a new model of real estate management and intermediation, which does not even require the purchase of the asset.

It works as follows. An owner enters the details of his property on the Viflip website. Once he has all the information, the company's fast algorithm analyzes thousands of similar homes in a matter of seconds and offers a maximum sale price for which the property could be sold.

If the owner agrees with the price, a Viflip agent will go to the property to analyze a series of renovations that will help the seller increase the maximum sale value.

Is Viflip only a sales consultant? Of course not. This is where the fundamental role of the company comes into play. It will be the company that will make the necessary investment to undertake the reforms that will increase the price of the property. The seller will not put a single penny at risk.

From that moment on, Viflip's agents will help the owner to find a buyer who will reach at least the maximum price that was indicated to him in his first consultation.

Viflip will only recover the investment made by selling the property if that amount has been reached. In this way you will get the value of the investment in the reform made and a commission for the sale.

In the meantime, the owner will get the sales price he had in mind at the beginning and a part of that plus that he has achieved together with Viflip.

Viflip brings to the United States a new way of running a Flipping House without the need to buy a property. A strategy that reduces the risk and time of each operation.

CONTACT:
Company Name: Viflip Consulting
Person Name: César Rivero
Email: info@viflip.com
Phone: +19292351240

SOURCE: Viflip Consulting

ReleaseID: 602967

LAS VEGAS, NV / ACCESSWIRE / August 24, 2020 / Alkame Holdings, Inc. (OTCPINK:ALKM), a publicly-traded holding company announces that its wholly-owned subsidiary West Coast Co Packer, Inc. has signed a Distribution and Manufacturing Agreement for the unique-to-the-marketplace Handout Protection brand of hand sanitizer. Handout Protection is innovatively packaged in single-use packets containing .13 fl. oz. (4mL) of bacteria and virus-fighting hand sanitizer. Presales begin immediately.

The Agreement signed between the Company, and Citadel Tea Technologies LLC designates West Coast Co Packer, Inc. to provide a best-in-class warehousing and logistics infrastructure along with exceptional customer service for Handout Protection's nationwide distribution channels.

Why Green Tea? Research findings have shown that green tea effectively fights alcohol-resistant bacteria and viruses. Containing a proprietary formulation of 75% pharmaceutical-grade Isopropyl alcohol and condensed organic green tea brewed in alkaline water, Handout Protection is manufactured in an FDA-registered facility under strict quality-control standards.

The single-use packets reduce the risk of touching contaminated pumps and dispensers. Handout Protection packets easily slip into a consumer's pocket or purse – eliminating the challenge of carrying a bulky bottle. The product line is…..Not Sticky! Soothing to the Skin! Cost-Effective!

"Our Company is eager to distribute Handout Protection to help meet the nation's unmet need at this critical time!" stated Robert Eakle Alkame Holdings, Inc CEO, "Unique in the marketplace, each single-use packet of Handout Protection provides an adequate amount (.13 fl. Oz) of hand sanitizer to cover an individual's entire hands (palms, top of hands, tips of fingers and between the fingers) along with the top and bottom of an individual's wrists – an often overlooked area requiring cleaning."

"In recent months, the FDA has banned over 100 hand sanitizer products due to the presence of harmful ingredients." said Eakle, "Handout Protection contains 75% pharmaceutical-grade Isopropyl alcohol and condensed green tea."

Competitively-priced in a 50-count or bulk SKUs, Handout Protection is perfect for a wide range of sales channels – Retail, Corporate, Food and Beverage Services, Restaurant, Hospitality, C-Stores, Airlines, Public Venues / Businesses, Healthcare, Consumer Households, Schools, and more. Consider purchasing for your employees' safety, as customer-service giveaways, and as Holiday gifting.

Eakle continued, "Shipping will begin in late-September 2020. Alkame management has been working diligently with Citadel Tea Technologies from concept to conception."

For distribution inquiries, please email info@westcoastcopacker.com or call 561.573.7200.

About West Coast Co Packer, Inc.

West Coast Co Packer, Inc., a specialty liquid and single-serve manufacturer, co-packer, private labeler, and contract packager, is expected to immediately complement and seamlessly integrate with Alkame's other subsidiaries including Bell Food and Beverage, Inc. Bell Food and Beverage, Inc. is a specialty natural, organic liquid-based hot and cold fill food and beverage manufacturer in glass and PET bottles and jars.

About Alkame Holdings, Inc.

Alkame Holdings, Inc. is a publicly-traded health and wellness technology holding company with a focus on patentable, innovative, and eco-friendly consumer products. The Company's wholly-owned subsidiaries manufacture products with enhanced water utilizing proprietary technology to create products with several unique properties. The organization is diligently building a strong foundation through the launch and acquisition of appropriate business assets, and by pursuing multiple applications and placement into several emerging business sectors including but not limited to the following: consumer bottled water, RTD products, liquid hemp-based products, household pet products, horticulture, agriculture, and medical applications, including hand sanitizers, and many other various water-based treatment solutions to both new and existing business platforms.

For more information, visit www.alkameholdingsinc.com.

CONTACT:
Tony Schor
Alkame Holdings, Inc. Investor Relations
Website: www.alkameholdingsinc.com
Email: info@alkameholdingsinc.com

Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

SOURCE: Alkame Holdings, Inc.

ReleaseID: 602765

Nasal Powder Spray May Provide Barrier for Cell Transmission of Respiratory Infections

WEST CHESTER, PA / ACCESSWIRE / August 24, 2020 / Virpax® Pharmaceuticals Inc. ("Virpax"), today announced the signing of a technology license agreement with Nanomerics Ltd. ("Nanomerics") for the exclusive North America rights to use Nanomerics' High-Density Molecular Masking Spray (MMS019) for the prevention of seasonal influenza and viral infections in humans. The formulation will be delivered using a preassembled device and cartridge to propel the High-Density Molecular Spray formulation into the nose. MMS019 will be used as a nasal powder spray to prevent viral binding to epithelial cells in the nasal cavity and the upper respiratory tract, which could significantly reduce respiratory related infections.

Among other uses, MMS019 is being developed to prevent SARS-COV-2 binding and entry to respiratory epithelial cells, by binding to epithelial cells in the nasal cavity and the upper respiratory tract. Virpax believes MMS019 may offer another layer of protection, in the form of a Molecular Mask, to be added to standard personal protective equipment to protect healthcare workers, and those at-risk of contracting serious diseases, from infection. MMS019 has completed IND-enabling toxicology studies and Virpax intends to develop this product for potential FDA accelerated review in healthy human volunteers as soon as possible.

"We believe MMS019 can work together with current personal protective equipment to enhance our ability to help prevent the spread of respiratory viral infections and seasonal influenza," said Anthony Mack, Chairman and Chief Executive Officer of Virpax.

"We are pleased that Virpax has licensed MMS019 for the prevention of viral respiratory infections and that they will undertake the clinical development of MMS019 to potentially bring a new respiratory infection prophylactic product to the market," said Ijeoma Uchegbu, Chief Scientific Officer of Nanomerics Ltd.

About Virpax Pharmaceuticals
Virpax Pharmaceuticals, Inc. is focused on developing branded prescription products and providing more efficient drug treatments using its proprietary cutting-edge delivery technologies designed to satisfy unmet global market needs. Virpax's pipeline consists of non-addictive products being studied to manage musculoskeletal pain, post-operative pain and moderate to severe chronic pain. While Virpax is a market leader in the development of non-addictive pain management products, Virpax is also using its patented delivery technologies to develop therapies to manage PTSD, as well as to help prevent viral spread, including influenza and SARS-CoV-2 (Covid-19). For more information, please visit www.virpaxpharma.com.

About Nanomerics Ltd.
Nanomerics is a specialty pharmaceutical company focused on the development of pharmaceutical products using its polymeric technologies. Nanomerics' proprietary technologies are based on world leading know-how and scientific leadership in polymeric nanotechnology. The founding scientists Professor Ijeoma F. Uchegbu and Professor Andreas G. Schätzlein developed these technologies at the Universities of Strathclyde and Glasgow and, later at the UCL School of Pharmacy.

Forward-Looking Statement
This news release contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are identified by terminology such as "may," "should," "expects," "plans," "anticipates," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential" or "continue" or the negative of these terms or other similar words. These statements are only predictions. Virpax cautions readers that forward-looking statements are based on management's expectations and assumptions as of the date of this news release and are subject to certain risks and uncertainties that could cause actual results to differ materially, including, but not limited to, those associated with the timing of MMS019 regulatory filings and clinical milestones and other risks and uncertainties. Accordingly, you should not rely upon forward-looking statements as predictions of future events. Forward-looking statements reflect the Company's analysis only on their stated date, and Virpax takes no obligation to update or revise these statements except as may be required by law.

CONTACT:
Shana Panzarella, Chief of Staff
Virpax Pharmaceuticals, Inc.
484-880-4588
info@virpaxpharma.com

SOURCE: Virpax Pharmaceuticals, Inc.

ReleaseID: 602814

TORONTO, ON / ACCESSWIRE / August 24, 2020 / Graycliff Exploration Limited. (the "Company" or "Graycliff") (CSE:GRAY) (FSE:GE0) is pleased to provide a corporate update regarding marketing and trading initiatives.

Graycliff is pleased to announce that it has commenced trading on the Frankfurt Stock Exchange ("Frankfurt Exchange") under the symbol "GE0" (G-E-Zero). The Company is committed to offering easy and transparent trading for current and future European investors. Trading information can be located on the Company's Frankfurt Exchange profile
(https://www.boerse-frankfurt.de/equity/graycliff-exploration-ltd)

The Company also announces that it has engaged Global Media Buyers ("Global Media") to execute a digital investor marketing campaign on Graycliff's behalf. Global Media will focus on investor awareness digitally in North America and Europe as the Company begins to roll out its 2020 Exploration campaign.

About Graycliff Exploration Limited.

Graycliff Exploration is a mineral exploration company focused on its 517 hectares of prospective ground, located roughly 80 kilometres west of Sudbury on the prolific Canadian Shield. The Company's Shakespeare Project consists of 24 claims on a property associated with the historic Shakespeare Gold Mine, which operated from 1903 to 1907.

For more information, contact investor relations at investors@graycliffexploration.com

On Behalf of the Board of Directors,

James Macintosh

President and CEO

Neither the Canadian Securities Exchange nor its regulation services provider has reviewed or accepted responsibility for the adequacy or accuracy of this press release.

This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of the Company. Forward-looking information is based on certain key expectations and assumptions made by the management of the Company. Although the Company believes that the expectations and assumptions on which such forward-looking information is based on are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Forward-looking statements contained in this press release are made as of the date of this press release. The Company disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities las.

SOURCE: Graycliff Exploration Ltd.

ReleaseID: 602983